CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
Ontology highlight
SUBMITTER: Morishima C
PROVIDER: S-EPMC4288749 | biostudies-literature | 2014 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA